Amgen Inc (AMGN)
NASDAQ · Healthcare · Drug Manufacturers - General
Amgen Inc is a Healthcare company with a market capitalization of $222.66B, a trailing P/E ratio of 25.6, and a dividend yield of 2.35%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | August 4, 2026 | $6.29 | $5.60 | +12.3% |
| Q1 2026 | April 30, 2026 | $5.15 | $4.77 | +8.0% |
| Q4 2025 | February 3, 2026 | $5.29 | $4.73 | +11.8% |
| Q3 2025 | November 4, 2025 | $5.64 | $5.01 | +12.6% |
| Q2 2025 | August 5, 2025 | $6.02 | $5.28 | +14.0% |
| Q1 2025 | May 1, 2025 | $4.90 | $4.26 | +15.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 12,845,008 | 2.36% | 6.4 | -0.2% |
| June 30, 2026 | 12,870,865 | 2.37% | 3.9 | +5.5% |
| June 15, 2026 | 12,200,158 | 2.24% | 4.1 | +2.9% |
| May 29, 2026 | 11,852,360 | 2.18% | 5.0 | -3.6% |
| May 15, 2026 | 12,289,634 | 2.26% | 4.3 | -5.2% |
| April 30, 2026 | 12,966,703 | 2.38% | 5.3 | +1.7% |
| April 15, 2026 | 12,744,432 | 2.35% | 5.3 | -8.8% |
| March 31, 2026 | 13,981,275 | 2.57% | 4.7 | -2.4% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Amgen Inc's market cap?
As of August 13, 2026, Amgen Inc (AMGN) has a market capitalization of $222.66B.
What is Amgen Inc's P/E ratio?
Amgen Inc trades at a trailing price-to-earnings (P/E) ratio of 25.6. Its forward P/E is 18.4.
Does Amgen Inc pay a dividend?
Yes — Amgen Inc pays a dividend yielding 2.35%, an annual payout of $9.80 per share.
What sector is AMGN in?
Amgen Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Amgen Inc's short interest?
As of the July 15, 2026 FINRA settlement, 12,845,008 AMGN shares were sold short, or 2.36% of shares outstanding. Days to cover: 6.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Amgen Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Amgen Inc reported revenue of $36.74B and net income of $7.71B.
Ask your own questions about AMGN
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.